No Need To Split Provigil Claims Before Trial, Cephalon Says
Cephalon Inc. resisted efforts Wednesday to separate certain Apotex claims from an upcoming trial in the pay-for-delay litigation over sleep-disorder medicine Provigil, telling a Pennsylvania federal judge it would unnecessarily complicate...To view the full article, register now.
Already a subscriber? Click here to view full article